title: Early or continued osteoporosis treatment during nonvertebral fracture-healing: no harm done commentary on an article by Silvano Adami, MD, PhD, et al.: ‘‘denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing. results from the FREEDOM trial’’.
authors.affiliation: University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: J Robert
authors.initials: JR
authors.lastname: Pignolo
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D000069448:Denosumab; D005260:Female; D005593:Fracture Fixation, Internal / Q000379:methods*; D017102:Fracture Healing / Q000187:drug effects*; D005598:Fractures, Spontaneous / Q000209:etiology*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D000069448:Denosumab